[8] [9] Semaglutide's gastrointestinal adverse effects, particularly nausea and vomiting, occur commonly during treatment initiation and dose escalation
In clinical trials, significant weight loss was observed within several weeks to a few months of starting treatment
Research shows that when people make the switch to tirzepatide, they lose even more body weight and achieve better blood sugar control in as little as three months
Always give your prescriber a complete list of everything you take, including over-the-counter products, vitamins and supplements, so they can check for interactions and advise on timing
If most people with fibrotic MASH are already eligible through their weight or their diabetes, then the patient in the endocrinology or primary care clinic with obesity and type 2 diabetes is very often the same patient with unrecognized liver fibrosis